The locoregional recurrence-free survival rates according to the location of the primary tumor, the local extension of the tumor, the presence of node metastasis, the type of treatment and the BMI, relating to the profiles of SUCNR1/SDHA expression are shown in Table 3. This evidence concerns the gene SDHA and neoplasm.